This trial is investigating how changes in the types of bacteria in the mouth may be related to the most common type of oral cancer, and whether a probiotic regimen may help prevent or rectify these changes.
- Oral Cancers
2 Primary · 0 Secondary · Reporting Duration: Up to 3 months
2 Treatment Groups
1 of 2
1 of 2
24 Total Participants · 2 Treatment Groups
Primary Treatment: ProDentis Lozenge · Has Placebo Group · N/A
Who is running the clinical trial?
Age 21 - 89 · All Participants · 2 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Frequently Asked Questions
Are there still opportunities available for participants in this experiment?
"According to the clinicaltrials.gov website, this research initiative is currently recruiting participants. It was posted on April 20th 2022 and its most recent update took place in August 4th of the same year." - Anonymous Online Contributor
Does the study accept participants who have surpassed 35 years of age?
"According to the criteria for enrolment, this medical trial requires participants of legal age or older and no more than 89 years old." - Anonymous Online Contributor
How many individuals are currently engaged in this experiment?
"Affirmative. According to the clinicaltrials.gov website, recruitment for this trial began on April 20th 2022 and was last updated on August 4th 2022. This study is looking for 24 individuals from a single site." - Anonymous Online Contributor
What are the eligibility requirements for participation in this trial?
"This clinical trial has a participant cap of 24 individuals, all of whom must possess oral neoplasms and be between the ages 21 and 89." - Anonymous Online Contributor